Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2018 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks if a substantial part of management's forward account consists of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, such that the company's own coming volume is a consequence of those parties' trajectories. Looking at the transcript, management discusses various topics: dispositions, leasing, Big Box Surge, 3-R projects, balance sheet, guidance. They mention specific leases signed (Gander Outdoors, Party City), but these are individual deals, not a narrative of counterparties' own expansion programs. They talk about fixed CAM, same-store NOI, etc. They mention Toys"R"Us impact, but that's a risk. They discuss SENA (Sears?) relationship, but that's about renewals and working relationship, not a growth trajectory. They mention Kroger Marketplace not opening, but that's a negative. They talk about leasing to various tenants, but not a coherent story of a counterparty scaling up. The management's forward account is mostly about their own leasing efforts, dispositions, and balance sheet. They do not describe a specific counterparty's own ramp or expansion as the driver of their future. They mention "we have five executed letters of intent" but that's their own pipeline. No mention of a major customer's multi-year build-out. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.